Welcome to LookChem.com Sign In|Join Free
  • or
Benzeneacetonitrile, 3-(trimethylsilyl)-, also known as 3-(trimethylsilyl)benzeneacetonitrile or (3-trimethylsilylphenyl)acetonitrile, is an organic compound with the chemical formula C11H15NSi. It is a colorless liquid that is soluble in organic solvents and has a molecular weight of 191.32 g/mol. Benzeneacetonitrile, 3-(trimethylsilyl)- is characterized by the presence of a benzene ring, an acetonitrile group, and a trimethylsilyl group. It is used as a reagent in organic synthesis, particularly in the preparation of various pharmaceuticals and agrochemicals. Due to its reactivity and potential applications, it is important to handle Benzeneacetonitrile, 3-(trimethylsilyl)- with care, following proper safety protocols.

5206-56-4

Post Buying Request

5206-56-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5206-56-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5206-56-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,0 and 6 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5206-56:
(6*5)+(5*2)+(4*0)+(3*6)+(2*5)+(1*6)=74
74 % 10 = 4
So 5206-56-4 is a valid CAS Registry Number.

5206-56-4Relevant academic research and scientific papers

Studies on the synthesis and biological properties of non-carrier-added [125I and 131I]-labeled arylalkylidenebisphosphonates: Potent bone-seekers for diagnosis and therapy of malignant osseous lesions

?rstad, Erik,Hoff, Per,Skatteb?l, Lars,Skretting, Arne,Breist?l, Knut

, p. 3021 - 3032 (2007/10/03)

Arylalkylidenebisphosphonates labeled with nca [125I or 131I] have been synthesized and their biological function investigated. The label was attached to the aromatic group in high yield and under mild conditions by means of iododesi

Bis-phosphonate compounds

-

, (2008/06/13)

The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a linker group; and Y is a moiety comprising two phosphonate groups. Further aspects of the invention relate to a method for palliative and curative treatment of bone disorders and cancer related disorders, such as breast cancer.

Bis-phosphonate compounds

-

, (2008/06/13)

The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a linker group; and Y is a moiety comprising two phosphonate groups. Further aspects of the invention relate to a method for palliative and curative treatment of bone disorders and cancer related disorders, such as breast cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5206-56-4